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ABSTRACT 
 
 
Self-management interventions (SMIs) are patient-centered and designed to foster active 
participation of patients in order to promote well-being and to manage symptoms.  Over the past 
two decades the role of self-management in chronic diseases has gained momentum. Self-
management programs are now acknowledged as a key element of quality care.  New modes of 
delivery allow greater access to information and are tailored to address patient needs.  This 
systematic review presents data from clinical studies of self-management over the past decade, 
summarizes the evidence for program effectiveness and suggests future research directions.  
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INTRODUCTION  
Self-management is the “individual’s ability to manage the symptoms, treatment, physical and 
psychosocial consequences and life style changes inherent in living with a chronic condition” 1.  
Whilst often instigated by individuals, health professionals, and patient organizations facilitate 
self-management in partnership with patients. Traditional patient education offers information and 
technical skills. In contrast, self-management interventions (SMIs) are problem focused, action–
oriented and emphasize patient-generated care plans 2.  SMIs include educational, behavioural 
and cognitive approaches to influence health knowledge, attitudes, beliefs and behaviours and to 
promote independence, maintain or adjust life roles and address the psychological impact of 
disease.   SMIs address five skills:  problem solving, decision-making, resource utilization, 
collaborative patient/provider relationships and taking action 3.  SMI success depends upon 
needs assessments identifying specific groups’ concerns.     
Importance and meaning of self-management for persons with arthritis   
Health professionals view SMIs as structured education to develop patients’ illness 
management skills.  However, patients view these differently4.  A qualitative study5 reported 
arthritis patients viewed SMIs as a way to bring order into their lives, helping them recognize 
boundaries, mobilize resources, cope with change in self-identity and plan, pace and prioritize.  
This study furthers the understanding of SMIs because it identifies and articulates the value of 
patient-centered approaches and has implications for SMI evaluation in terms of frequency and 
methodology.  SMI evaluation occurs in stages; pre-, intra- and post-intervention, representing a 
series of snapshots along a continuum and may miss the full impact on the patient. Additionally, 
differences in outcome data may occur based on who has asked questions and how questions 
were asked. 
History of self-management programs   
 In the 1980s, Lorig and associates developed the Arthritis Self-Management Program 
(ASMP) to enhance well-being and quality of life.  The original ASMP was not theory based but 
considered knowledge leads to behaviour change.  During program evaluation participants linked 
 4
program satisfaction with an increased sense of disease control 6 thus Bandura’s Social Cognitive 
Theory 7 was selected as a framework for change. As more SMIs developed, researchers 
recognized the value of peer- as well as professional- led programs 8.  Lorig’s ASMP is the most 
developed and studied of SMIs and is disseminated by patient organizations across the globe.   
Most SMI research evaluates group programs delivered face-to-face.  Financial constraints, 
increasing access and technology have driven mailed and internet program development. The 
ASMP group (Stanford University, USA) leads the way developing new technologies for self-
management.  However, many SMIs are still delivered one-to-one by health professionals, the 
least evaluated delivery mode.  
 
 
EVIDENCE FOR EFFECTIVENESS OF SELF-MANAGEMENT PROGRAMS 
 
Several systematic reviews of arthritis patient education and SMIs have evaluated studies 
published up to 2002. Reviews of rheumatoid arthritis (RA) SMIs concluded only those using 
psychobehavioural approaches led to short-term (up to 9 months) significant improvements in 
functional disability, but effects are not sustained 9,10 .  Osteoarthritis (OA) and RA study reviews 
concluded 40% of SMIs led to improved symptoms and disability 11,12. Effective programs were 
more common in OA than RA, possibly because OA SMIs more frequently included exercises 
and recruited larger samples. Programs based on cognitive-behavioural theory (CBT) or social 
cognitive theory (SCT) yielded better outcomes. Few studies examined effectiveness for 12 
months or more. Two systematic reviews of SMI trials in FM concluded that multimodal 
interventions yielded better outcomes than single mode interventions but improvements were 
modest and not maintained 13,14 .  
Methodological limitations of SMI trials were highlighted such as: insufficient patient-relevant 
outcomes, lack of consensus for outcomes and patient attributes examined; and low statistical 
power. Recommendations for future SMI trials included:  use of OMERACT core sets; 
assessment of fatigue and social participation; sufficient power; be disease specific; identify 
which patient and program characteristics yield beneficial outcomes; explicitly state theoretical 
basis; publish program protocols /manuals; use leaders trained in group facilitation, problem-
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solving, goal-setting and CBT and/or SCT approaches; and use strategies for long-term 
behavioural change (eg booster sessions) 10,12 . 
For this review, Medline, PubMed, EMBASE, CINAHL, AMED, PsychInfo and the Cochrane 
Library were searched from 2000 for FM, from 2003 for OA and RA and up to November 2009 
using key terms of “arthritis,” “osteoarthritis, ” “rheum$,” “fibromyalgia,” “self-management,” self 
care ” and  “patient education.”  Studies were included if they: were in English; involved 
randomization; and stated they were SMIs. In total, 30 articles were identified meeting the entry 
criteria; some were economic evaluations and long-term follow-ups of earlier trials. Studies were 
excluded if only reporting observational data or long-term follow-up data from previous trials 
without comparison group data. This review aims to identify whether longer-term (ie >= 12 
months) benefits resulted, by diagnosis and if any program or patient characteristics are 
associated with improvement. 
 
SMIs for individuals with  either OA, RA or other arthritic conditions. 
 Seven studies were identified: two being published within one article and three articles related 
to one study 15-22. See Table 1.  Fifty to 75% of participants had OA, 15 to 35% RA and 15 to 17% 
other diagnoses. Two studies included between 30-52% of people with FM (who could have other 
arthritis diagnoses) 17,21.  Six studies evaluated the ASMP or variations thereof, all including 
weekly exercise practice (stretch, strength and walking). Two evaluated the ASMP 16,21; two a 
mailed, individualized version of the ASMP (SMART: provided over 12-18 months) 15; one an 
internet- ASMP 17; and one a “one-time” mailed ASMP version 22. The seventh evaluated the 
individually tailored “I’m Taking Charge of My Arthritis” (ITCA) program provided in individual 
home visits 18-20. All were community or home-based and all (apart from the ITCA study led by 
health professionals) led by either peer moderators or self-completed.  All programs involving 
contact lasted 6 weeks (in person or internet) and the other two self-completed at a pace to suit 
participants.  Two studies included booster sessions 15,18,19. Apart from the ITCA, all programs 
included similar ASMP content and teaching strategies. Cognitive and behavioural strategies 
were taught by trained leaders, following the ASMP leader manual, using SCT approaches to 
 6
facilitate change.  
  Methodologically, five studies used intent-to-treat (ITT) analysis 15,16,22 (and only four included 
control groups 15,17,18,22 .Two conducted a priori sample size analyses and recruited sufficient 
participants 21,22 and a further four 15-17recruited between 340-1090 patients suggesting these 
were large enough to detect differences. 
All studies evaluated pain, function, mood, self-efficacy, and health behaviors. (Table 5). Five 
reported follow-ups of 12 months or longer 15-17,21.  At 12 months, all five demonstrated 
improvements in self-efficacy; four in function (Lorig et al 2004, 2005, 2008); two in pain 15,18; and 
one in mood 18.  The least effective ASMP recruited predominantly African American participants 
21
. Most effective ASMP studies were delivered to predominantly non-Hispanic white participants, 
either face to face15 or via the Internet 17. Most participants (64-75%) had OA. Only one study 
conducted sub-group analyses by diagnoses, demonstrating the Internet ASMP was most 
effective in OA, next in RA and not at all in FM 17. Follow-up longer than 12 months occurred in 
only one study with a control group comparison. At two years, the SMART programme, including 
booster materials, reduced perceived arthritis severity and doctor visits but by three years, there 
were no differences 15.  
SMIs for individuals with osteoarthritis 
 Eight studies were identified 23-30. Economic analyses were conducted for two studies 31,32.  
See Table 2. Three studies enrolled only patients with knee OA and five patients with hip and/or 
knee OA.  Three used a cluster RCT approach with medical practices as the unit of analysis 
23,24,28
.  Most participants, approximately 75%, were women.  Three studies evaluated the group-
format ASMP 25,29,30. Five evaluated other SMIs, comparing these to usual care or information 
booklets 23,24,26-28.  Three studies were group interventions: two combining SMIs with supervised 
and home exercise practice 24,27; and two evaluated individual SMIs 26,28.  Most group 
interventions lasted 12 hours over 6 weeks, apart from one of four hours plus an individual home 
visit 23. None included booster sessions. Individual interventions lasted one hour26 or duration was 
not stated 28, with both including telephone follow-up. All but one study 29 recruited patients from 
primary care. All but one 25 were led by a health professional, either GP, nurse and/or physical 
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therapist, and group SMIs used SCT approaches. Methodologically, five studies used ITT 
analysis 25,27-30 and a priori power calculations were reported in four. (See Table 2) 
All studies evaluated pain and function; four also examined health knowledge, behaviors and 
care use; three measured self-efficacy; but mood and fatigue were infrequently assessed (See 
Table 5).  Four studies only reported short-term outcomes (between 4 to 9 months): with three 
reporting improvements in pain and function 27-29; and one brief individual SMI reporting no 
differences26.  Two studies found no significant differences in outcomes at any follow-up, both 
having shorter duration interventions of one or five hours 23,26.  Two studies 24,25 included 
economic analyses.  Whilst both had health benefits only one demonstrated cost-effectiveness32: 
a group format being better than individual interventions27.  Overall, of the four studies evaluating 
long-term outcomes (ie 12 months or longer) significant, modest effects were found for: pain 24,30; 
self-efficacy 25,30; function 24 and mood25. The most effective interventions longer-term were 
protocolized group SMIs, including six weeks of supervised exercise, using either CBT or SCT 
approaches led by trained leaders 24,30.   
 
SMIs for individuals diagnosed with inflammatory arthritis 
Five studies were identified 33-37 (Table 3).  Four recruited people with RA only and one, 
pragmatically, RA (50%), early inflammatory arthritis (35%) and psoriatic arthritis (14%) 37. Three 
studies recruited people with well-established disease (average 12-15 years) and two early to 
established disease 34,37.  Studies showed some similarities: all evaluated small group programs 
(up to 10 participants), were hospital-based and led by health professionals. All except one34 had 
control groups, either usual care, information booklets or attention control (an information 
program).  All used ITT analysis. In other respects studies were diverse. Sample sizes ranged 
from 59 to 218, with only three reporting sample size analyses and recruiting sufficient 
participants to detect differences 33,36,37.  
Programme duration varied from 12 -52 hours, over 6 weeks to 9 months, with three including 
booster sessions (between 3 to 9 months post-programme).  Programs also varied in content and 
delivery. All provided information about the disease and medications. Four explicitly used SCT 
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and/or CBT approaches. Two were led by clinical psychologists using CBT combined with 
education from multidisciplinary team members using “more traditional didactic approaches” for 
physical strategies 34,35. Two described use of leader manuals, staff training in SCT/CBT 
approaches and applying these throughout programs 33,37. One study did not explicitly describe its 
theoretical framework 36.  Only two included regular exercise 36,37.  
All studies evaluated pain, function and mood. Disease status and self-efficacy were 
measured in four and fatigue in three studies (Table 5). Short-term benefits were found in four 
studies. Three had longer-term follow-up at 12 months but only two showed benefits 33,37. Both 
used SCT/CBT approaches throughout the programs, specially trained health professionals and 
longer-term booster sessions. Riemsma et al 33 identified improved self-efficacy and fatigue in 
people attending a primarily cognitive strategy SMP without their partner, whilst those attending 
with partners showed no sustained benefits.  Hammond et al 37 (2008) showed significant 
improvements in pain, self-efficacy, perceived control and health behaviours. This was the only 
program consistently enabling both cognitive and behavioural strategies using SCT/CBT 
approaches with substantial skills practice. Patients also had shorter disease duration (average 7 
compared to 12-15 years).  
SMIs for individuals diagnosed with fibromyalgia 
Seven studies were identified 38-44 (Table 4). Five recruited people from secondary care 
diagnosed with FM by rheumatologists using ACR criteria and two recruited patients from primary 
care diagnosed by General Practitioner 38,42.   Programs were similar with respect to group size 
(up to 12 participants) and leadership (health professionals). Additionally, an eighth study 
(Internet- ASMP) reported FM results separately 17(Table 1).  Most studies included a control 
group of usual care, wait list control, information leaflets or an attention control (relaxation) group. 
Only one had no control group, comparing exercise, SMI or combined exercise and SMI 44. 
Sample sizes ranged from 53 to 207, with all but two 38,40 including sample size calculations and 
recruiting sufficient numbers to potentially demonstrate differences.  Only four included ITT 
analysis17,39,42,43. Program duration varied between 18 – 50 hours, with four being wholly or 
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partially community based (e.g. leisure centres, YMCAs).  Four programs lasted between 2.5 to 6 
weeks and four between 10-16 weeks. None included booster sessions.  
All programs included information about FM and its management. Nine different SMIs were 
evaluated, as one study evaluated two styles of SMI 38. Of these, six explicitly used SCT and/or 
CBT approaches with four reporting use of trained leaders experienced in these (CBT group 
only38); 17,43,44.   All included cognitive components (e.g. managing pain, relaxation) and six 
included supervised exercise practice. A systematic review identified supervised moderate 
intensity aerobic exercise (minimum 12 weeks, 3x/week) is effective in FM 45. However, only two 
programs combined SMIs with this exercise intensity 39,44, with only one showing short-term 
improvements 44. Three studies included at least 10 sessions of supervised exercise spread over 
6– 10 weeks 40,42,43 .  
All studies evaluated pain, function, perceived health and mood. Fatigue was measured in 
seven, self-efficacy and social role/support in four, health behaviours in three and health care use 
in only two (see Table 5). Considering studies using either case-completer or ITT analysis, short-
term benefits were found for 4-6 months in three studies for three or more outcomes 40,43,44. Three 
had controlled follow-ups between 8-12 months 17,41,43 but only two showed minimal continued 
benefits: in fitness 41 and self-reported improvement 43. In summary, no FM studies showed SMIs, 
with or without exercise, sustained benefits across a range of outcomes for more than 6 months.  
SUMMARY OF THE EVIDENCE 
  
Previous reviews have identified psychobehavioural SMIs lead to short-term benefits (ie 6-9 
months) but that longer-term benefits are infrequently evaluated and rarely sustained 12,33. In this 
updated review we aimed to identify whether recent SMI trials identify any longer-term benefits 
and whether any program, diagnostic or patient characteristics are associated with improved 
outcomes. 
Of the 30 studies identified, only 14 had follow-ups of 12 months or longer, seven of which 
(two of the same SMART ASMP) led to sustained benefits in pain and/ or function.  All were 
methodologically sound.  Little is known about benefits beyond 12 months as only two had 
longer-term follow-ups, although both demonstrated some continuing benefits 15,24.  The ASMP 
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leads to sustained benefits over four years and is cost-effective 46, but more research is needed in 
other SMIs. We recommend SMI studies demonstrating benefits at 6-12 months seek funding to 
extend follow-up and evaluate cost-effectiveness, to provide data for service development 
decisions. 
In terms of program characteristics, the seven effective SMIs were either the group 
ASMP, a variant (SMART or internet versions) 15-17,30 or acknowledged ASMP influence on 
structure and format 24,37. Thus, common program features were: duration of at least six weeks; 
explicit use of SCT and/or CBT approaches; individualized weekly action plans with progress 
review; highly protocolized with participant handbooks; and led by the same trained leaders.  All 
face-to-face programs included weekly supervised exercise and graded home aerobic exercise 
(eg walking, Tai Chi). Three included aerobic exercise within programs 25,30,37 and the mailed/ 
internet ASMPs strongly promoted exercise action-planning with clear details about exercise 
performance. We recommend these strategies be incorporated into clinical programs and in 
research trials. Evidence-based guidelines should include studies meeting SMI criteria 3 and not 
treat all interventions equally.  Whilst eight studies used boosters 15,18,19,20,28,33,35-37 only three 
showed significant benefits 15,28,37.  Further evaluation of the timing, delivery (phone, mailing or 
group) and effectiveness of booster sessions is warranted.  
In terms of patient characteristics, there is little research regarding who benefits most 
from SMIs. The majority of ASMP trials recruited community or online volunteers, who may be 
more motivated to change. In ASMP studies recruiting from primary or hospital settings (all with 
OA) there is conflicting evidence, as two studies (with enhanced exercise) were effective 29,30 but 
a third, was not 25, supporting an earlier study’s  findings 47. Only one ASMP trial has evaluated 
whether different diagnostic groups fare better, concluding the internet version is more effective in 
OA, less so in RA and not in FM 17.  Another study 33 reported patients with RA attending without 
their partner fared better, as they could openly discuss problems without loved ones present. 
Additionally, those not benefitting seemed less motivated to participate and change, had poorer 
heath and more stressful life events 4. In an FM study, patients with initially higher self-efficacy 
 11
reported greater improvements 43. Further research is needed to appropriately target 
interventions and/or modify SMIs to meet the needs of specific patient groups.   
FUTURE DIRECTIONS   
 
To best address the needs of patients with arthritis, we recommend researchers 
demonstrating positive outcomes from SMIs with sufficient sample sizes, undertake secondary 
analyses to investigate whether any baseline characteristics may predict better outcomes. We 
also recommend evaluating longer-term (12 months or more) benefits of SMIs, using protocolised 
SCT/CBT based programs of sufficient duration, incorporating exercise for 6 sessions or more, 
(longer for FM, including twice-weekly supervised graded aerobic exercise), led by either 
specially trained health professionals or peer leaders and which incorporate assessment of 
patient-relevant outcome.   Increased use of qualitative methods integrated into clinical trials (eg 
patient dairies (written or audiorecorded), focus groups or interviews) are suggested to promote 
participants’ expression of any perceived benefits on overall well-being, and to explore their 
perspectives on SMI effectiveness, as opposed to the sole use of questionnaires using standard 
validated tools which may not be detecting meaningful differences to the patients.  For example, a 
woman attending a SMI course reported walking to her local shops for the first time in 12 years. 
Taking over two hours to make the 200 yard trip was entirely irrelevant to her. Such change is not 
captured in outcome measures.  Her ability to control to her life was her relevant outcome. Use of 
such qualitative approaches will help investigate the full impact of SMIs on individuals, determine 
the most patient-relevant outcomes for future trials, investigate the process of change and shed 
light on what patient attributes influence benefits (or lack of) to better target and time SMIs. See 
Table 6.   
 12
REFERENCES  
 
1.  Barlow J, Wright C, Sheasby J et al. Self-management approaches for people with chronic 
conditions: a review. Patient Education and Counseling   2002;48:177-187. 
2.  Lorig KR, Holman HR.  Self-management education: History, Definition, Outcomes, and 
Mechanisms.    Ann Behav Med  2003;26: 1-7. 
3.  Center for the Advancement of Health: Essential elements of self-management interventions.  
Washington, DC: Center for the Advancement of Health, 2002. 
4.  Bode C, Taal E, Emons PA, Galetzka M, Rasker JJ, van de Laar.  Limited results of group 
self-management education for rheumatoid arthritis patients and their partners: Explanations from 
the patient perspective.  Clin Rheumatol  2008;27:1523-1528. 
5.  Kralik D, Koch T, Price K, Howard N. Chronic illness self-management: Taking action to create 
order. J Clinical Nurs 2004:13:259-267. 
6.  Lorig KR, Seleznick M, Lubeck D et al.  The beneficial outcomes of the arthritis self-
management course are not adequately explained by behavior change.  Arthritis Rheum  
1989;32: 231-243. 
 
7.  Bandura A. Self-efficacy: Toward a unifying theory of behavior change. Psychol Rev 
1977;84:191-215. 
8.  Lorig K, Feigenbaum P, Regan C, Ung E, Chastain RL, Holman HR.  Comparison of lay-
taught and professional-taught  arthritis self-management courses. J Rheumatol 1986;13:763-
767. 
9.  Niedermann K, Fransen J, Knols R, Uebelhart D. Gap between short-and long-term effects of 
patient education in rheumatoid arthritis patients: a systematic review. Arthritis Rheum 
2004;51:388-398. 
10.  Riemsma R, Taal E, Kriwan J, Rasker JJ. Systematic review of rheumatoid arthritis patient 
education. Arthritis Rheum 2004;51:1045-1059. 
11.  Warsi A, LaValley MP, Wang PS, Avorn J, Solomon DH. Arthritis self-Management 
Programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum 2003;48:2207-
 13
2213. 
12.  Newman S, Steed L, Mulligan K. Self-management interventions for chronic illness. The 
Lancet 2004;364:1523-1537. 
13.  Karjalainen KA, Malmivaara A, van Tulder MW, Roine R, Jauhiainen M, Hurri H, Koes BW. 
Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. 
Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No.: CD001984. DOI: 
10.1002/14651858.CD001984. 
14.  Sim J, Adams N. Systematic review of randomised controlled trials of nonpharmacological 
interventions for fibromyalgia. Clinical J Pain 2002;18:324-336. 
15.  Lorig KR, Ritter PL, Laurent DD, Fries JF.  Long-term randomized controlled trials of tailored-
print and small-group arthritis self-management interventions.  Medical Care  2004;42:346-354. 
16.  Lorig K, Ritter PL, Plant K.  A disease specific self-help program compared with a 
generalized self-help program for arthritis patients. Arthritis & Rheumatism 2005;53:950-957. 
17.  Lorig K, Ritter P, Laurent DD, Plant, K.  The Internet-based arthritis self-management 
program: A one-year randomized trial for patients with arthritis or fibromyalgia.  Arthritis Rheum 
2008;58:1009-1017. 
18.  Nour K, Laforest S, Gauvin L, Gignac M.  Behavior change following a self-management 
intervention for housebound older adults with arthritis: An experimental study.  Int J Behavioral 
Nutrition and Physical Activity  2006;3:12 (doi:10.1186/1479-5868-3-12). 
19.  Nour K, Laforest S, Gauvin L, Gignac M. Long-term maintenance of increased exercise 
involvement following a self-management intervention for housebound older adults with arthritis.  
Int J Behav Nutr Phys Act. 2007; 4:22. doi: 10.1186/1479-5868-4-22. 
20.  Laforest S, Nour K, Gignac M, et al. Short-term effects of a self-management intervention on 
health status of older housebound adults with arthritis. Journal of Applied Gerontology 
2008;27:539-567 
21.  Goeppinger J, Armstrong B, Schwartz T, Ensley D, Brady TJ.  Self-management education 
for persons with arthritis: Managing comorbidity and eliminating health disparities.  Arthritis 
Rheum[Arthritis Care Res]  2007;57:1081-1088. 
 14
22.  Goeppinger J, Lorig K, Ritter PL, Mutatkar S, Villa F, Gizlice Z. Mail-delivered arthritis self-
management tool kit: a randomized controlled trial and longitudinal follow-up. Arthritis & 
Rheumatism 2009;61:867-875. 
23.  Victor CR, Triggs E, Ross F, Lord J, Axford JS. Lack of benefit of a primary care based 
nurse-led education programme for people with osteoarthritis of the knee. Clinical Rheumatology 
2005;24:358-364. 
24.  Heuts PH, de Bie R, Drietelaar M, Aretz K, Hopman-Rock M, Bastiaenen CH, Metsemakers 
JF, van Weel C, van Schayck O.  Self-management in osteoarthritis of hip or knee: a randomized 
clinical trial in  a primary healthcare setting. Journal of Rheumatology 2005;32:543-54 
25.  Buszewicz M, Rait G, Griffin M, Nazareth I, Patel A, Atkinson A, Barlow J, Haines A. Self 
management of arthritis in primary care: randomized controlled trial. British Medical Journal 2006; 
doi:10.1136/bmj.38965.375718.80 
26. Wetzels R, van Weel C, Grol R, Wensing M .  Family practice nurses supporting self-
management in older patients with mild osteoarthritis: A randomized trial. BMC Family Practice  
2008;9:7; doi: 10.1186/1471-1-2296-9-7. 
27.  Hurley MV, Walsh NE, Mitchell HL, Pimm TJ, Patel A, Williamson E, Jones RH, Dieppe PA, 
Reeves BC (2007a). Clinical effectiveness of a rehabilitation program integrating exercise, self-
management and active coping strategies for chronic knee pain: a cluster randomised controlled 
trial. Arthritis and Rheumatism 2007a;57:1211-1219. 
28.  Rosemann T, Joos S, Laux G, Gensichen J, Szecsenyi J. Case management of arthritis 
patients in primary care: a cluster-randomised controlled trial. Arthritis  Rheum 2007;57:1390-
1397. 
29.  Yip YB, Sit JWH, Fung KKY, Wong DYS, Chong YC, Chung LLH, Ng TP.  Effects of a self-
management arthritis programme with an added exercise component for osteoarthritic knee: 
randomized controlled trial.  J Advanced Nursing  2007;59:20-28.  
30.  Yip YB, Sit JWH, Wong DYS, Chung LLH.  A 1-year follow-up of an experimental study of  a 
self-management arthritis programme with an added exercise component of clients with 
osteoarthritis of the knee.  Psychol Health Med  2008;13:402-414. 
 15
31.  Patel A, Buszewicz M, Beecham J, et al Economic evaluation of arthritis self-management in 
primary care. British Medical Journal 2009;339:b3532 . 
32.  Hurley MV, Walsh NE, Mitchell HL, Pimm TJ, Williamson E, Jones RH, Reeves BC, Dieppe 
PA,  Patel A.  Economic evaluation of a rehabilitation program integrating exderrcise, self-
management and active coping strategies for chronic knee pain. Arthritis and Rheumatism 2007b; 
57: 1220-1229 
33.  Riemsma RP, Taal E, Rasker JJ. Group education for patients with rheumatoid arthritis and 
their partners. Arthritis Rheum 2003;49:556-566 
34.  Van Lankveld W, van Helmond T, Naring G, de Rooij DJ, van den Hoogen F. Partner 
participation in cognitive-behaioural self-management group treatment for patients with 
rheumatoid arthritis. J Rheumatol 2004;31:1738-1745. 
35.  Kirwan JR, Helwtt S, Cockshott Z, Barrett J. Clinical and psychological outcomes of patient 
education in rheumatoid arthritis. Musculoskeletal Care 2005;3:1-16 
36.  Giraudet-leQuintrec J-S, Mayoux-Benhamou A, Ravaud P, et al. Effect of a collective 
educational program for patients with rheumatoid arthritis: a prospective 12-month randomized 
controlled trial. Journal of Rheumatology 2007;34:1684-1691. 
37.  Hammond A, Bryan J, Hardy A.  Effects of a modular behavioral arthritis education 
programme: A pragmatic parallel-group randomized controlled trial.  Rheumatology  
2008;47:1712-1718. 
38.  Soares JJF, Grossi G. A randmoised controlled comparison of educational and behavioural 
interventions for women with fibromyalgia. Scandinavian J Occupational Therapy 2002;9:35-45. 
39.  King SJ, Wessel J, Bhambhani Y, Sholter D, Maksymowych W. The effects of exercise and 
education, individually or combined, in women with fibromyalgia. Journal of Rheumatology 
2002;29: 2620-2627. 
40.  Cedraschi C, Desmeules J, Rapiti E et al.  Fibromyalgia: a randomized controlled trial of a 
treatment programme base don self-management. Annals of the Rheumatic Diseases 
2004;63:290-296 
41.  Ziljstra TR, van der Laar MAFJ, Bernelot Moens HJ et al (2005) Spa treatment for primary 
 16
fibromyalgia syndrome: a combination of thalassotherapy, exercise and patient education 
improves symptoms and quality of life. Rheumatology 2005;44:539-546 
42.  Lemstra M, Olszynski WP. The effectiveness of multidisciplinary rehabilitation in the 
treatment of fibromyalgia: a randomized controlled trial.  Clin J Pain. 2005;21:166-74. 
43.  Hammond A, Freeman K.  Community patient education and exercise for people with 
fibromyalgia: A parallel group randomized controlled trial.  Clinical Rehabil  2006;20:835-846. 
44.  Rooks DS, Gautam S, Romeling M, Cross ML, Stratigakis D, Evans B, Goldenberg DL, 
Iversen MD, Katz JN. Group exercise, education and combination self-management in women 
with fibromyalgia: a randomised trial. Archives Internal Med 2007;167:2192-2200. 
45.  Busch AJ, Barber KA, Overend TJ, Peloso PMJ, Schachter CL. Exercise for treating 
fibromyalgia syndrome. Cochrane Database of Systematic Reviews 2007;4. No.: CD003786. 
DOI: 10.1002/14651858.CD003786.pub2. 
46.  Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-
management in patients with chronic arthritis has sustained health benefits while reducing health 
care costs. Arthritis Rheum 1993;36:439-446. 
48.  Solomon  DH, Warsi A, Brown-Stevension T et al. Does self-management education benefit 
all populations with arthritis? A randomized controlled trial in a primary care physician network. J 
Rheumatol 2002;29:362-368 
 17
 18
Table 1:  Studies of Self-Management in Persons with Arthritis (Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia and other arthritic 
conditions 
Author (yr) 
 
Design and Sample (n): 
Diagnoses (%); 
Mean age (y); % women; 
arthritis duration (y) 
Recruitment 
source 
% Drop out 
 
Intervention, Duration, Booster, 
Comparison Group 
Facilitator; 
Training 
provided 
(Y/N) 
Theory 
 
 
Follow-
up 
Significant Outcomes: 
Improved 
Lorig et al  
(2004) 15 
RCT n=1090  
OA (40%); RA (60%);  
 
62 y;  77 % women 
 
Duration - not stated 
CV 
 
Drop-out: 
 
12m: 10% 
24m:   9%  
36m: 15% 
(a) SMART (individually 
tailored print materials 
based on the ASMP) plus 
the Arthritis Helpbook. 
Booster: follow-up materials 
every 4 months for 12 to 18 
months.  
(b) usual care 
Self-
completed 
SCT 12, 24 
and 36m 
CC and ITT analysis 
12m: SMART: 
function, role 
function, self-efficacy 
24m: global severity, 
doctor visits  
36m: no difference  
Lorig et al  
(2004) 15 
Randomized parallel 
group trial n=341  
OA (70%); RA (30%);  
 
65 y;  75% women 
Duration- not stated 
CV 
 
Drop-out: 
 
12m:  5% 
24m:  7% 
34m: 21% 
 
(a) SMART (as above) 
(b) 6 x 2h/ wk ASMP (6 x 
2h/week: action-planning, 
problem solving, decision-
making; exercise, cognitive 
symptom, pain, fatigue, 
sleep management; 
nutrition, communication 
plus Arthritis Handbook. No 
booster.  
 
No control group 
PM  (Y) SCT 12 ,24 
and 36m 
ITT analysis 
12m: SMART: 
function, social role 
function,  self-efficacy   
24m: no differences 
36m: ASMP: social 
role function, doctor 
visits 
Lorig et al 
(2005) 16 
Randomized parallel 
group trial n=355  
OA (75%); RA (15%); 
Other (15%) 
 
65y; 85% women;  
Duration – not stated 
CV 
 
Drop-out: 
 
  4m:   9% 
12m: 15% 
 
 
(a) ASMP 6 x2h/wk (see 
above) 
(b) CDSMP 6 x2h/wk (content 
similar to ASMP 
(No booster either group) 
 
No control group 
 
PM (Y) SCT 4 and 
12m 
ITT analysis:  
12m: Within group: 
ASMP pain, fatigue, 
self-efficacy, health 
distress, activity 
limitation, exercise.  
CDSMP: global 
health, activity 
limitation, exercise.  
12 m: Between 
group: ASMP  
fatigue, global health  
Nour et al RCT n=125 housebound  CHC (a) Self-management HP (Y) CBT 1w and CC analysis 
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(2006, 
2007); 18, 19 
Laforest et 
al (2008) 20 
113 randomized 
 
OA 65%; RA 35% 
78y; 90% women 
Duration- not stated 
 
Drop-out: 
 
 
8m 22% 
 
programme: “I’m Taking 
Charge of my Arthritis.“ 
(ITCA: exercise; relaxation; 
everyday coping 
behaviours; leisure 
activities; social networking)  
Individually tailored 6 x 
1h/wk home visits by health 
care practitioner; Booster: 
42% monthly telephone 
calls for 6m  
(b) one year wait list control 
8m 1w:  ITCA: function, 
helplessness,  
behaviours (exercise, 
relaxation)  
8m: exercise  
Goeppinger 
et al (2007) 
21
 
Randomized  parallel 
group trial n= 416 
(predominantly African 
Americans)  
Diagnosis: “arthritis”  
 
64y; 82% women;  
Duration – not stated 
CV 
 
Drop-out 
4m: 23% 
 
12m: 60% 
(but only 40% 
contacted) 
(a) ASMP 6 x2h/wk 
(b) CDSMP 6 x2h/wk 
(No booster either group) 
 
No control group 
PM (Y) SCT 4 and 
12m 
CC analysis: 
4m:  Both groups: 
self-efficacy, global  
health.  
ASMP group: 
exercise use 
CDSMP:  pain. 
12m: ASMP only: 
self-efficacy  
Lorig et al 
(2008) 17 
RCT n= 855  
 
OA 64%; RA 28%; FM 
52%; Other 14% 
 
52y; 60% women; 
duration – not stated 
CV 
OV 
 
Drop-out: 
  6m 25% 
12m 24% 
(a) Internet –based ASMP log-
on   1-2h >=3x/wk for 6 
wks: self-tests; read 
information; post action 
plans, participate in 
discussion board; tailored 
exercise programme; 
Arthritis Helpbook. No 
booster. 
(b) Usual care  
PM (Y) SCT 6 and 
12m 
ITT analysis:  
12m: IASMP: pain, 
activity limitation, 
global health, self-
efficacy, health 
distress. 
  
OA only (n=292): as 
above + function, 
fatigue 
RA only (n=144): 
pain, activity 
limitation, global 
health only. 
FM only (n=86): no 
differences. 
Goeppinger 
et al (2009) 
RCT n= 921  
three ethnic/racial 
CV (90%) 
 
(a) Mailed ASMP-based  Tool 
Kit (TK): self-test to 
Self-
completed 
SCT 4 and 
9m  
ITT analysis: 
 
 20
22
 categories. 
 
OA 51%; RA 33%;  
FM 30%; Other 17%. 
 
54y; 86% women; 
duration – not stated 
  
Rheum.  
(10%) 
 
Drop-out: 
 
4m 16% 
9m 30% 
evaluate arthritis impact 
and tailoring selected 
information; information 
sheets for e.g. exercise, 
dealing with emotions, 
fatigue/ pain management, 
HP communication; how to 
action plan, problem solve, 
decide what to try, 
individualize exercise; 
Arthritis Helpbook and 
relaxation/exercise CDs. No 
booster.  
(b) 4m wait list control group.  
4m: TK: pain, fatigue, 
function, global 
health, self-efficacy, 
depression, health 
distress, exercise, 
doctor 
communication.  
9m: (No control group 
comparison).  
Benefits sustained.  
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Table 2: Studies of Self-Management in Persons with Osteoarthritis Only 
 
Author (yr) 
 
Design and Sample (n): 
Mean age (y); % women; 
arthritis duration (y) 
Recruitment 
source 
% Drop out 
 
Intervention, Duration, 
Comparison Group 
Facilitator 
Training 
provided 
(Y/N) 
Theory Follow-
up 
Significant Outcomes: 
Improved 
Victor et al 
(2005) 23 
Cluster RCT of 22 
practices for n=193 
patients with knee OA 
 
 63.5 y ; 69% women 
Duration – 55% had OA 
for more than 3 years 
PC 
 
Drop out: 
12m 35% 
(a) Home visit to review goals, 
educational booklet and 4 
x1 h group teaching 
sessions (6 to 8 
participants) led nurse 
educator at GP office 
(b) Educational leaflet about 
arthritis only  
RN ( NS) Not 
stated 
1, 3, 6 
and 12m 
 CC  analysis 
1 and 12m: No 
differences  
Heuts et al 
(2005) 24 
RCT n=297 Hip and/or 
knee OA aged 40-60 
years. 
 
51.5y; 60 % women 
Duration – not stated 
 
 
PC 
 
Drop out: 
3m: 9% 
21m: NS  
 
(a) SMP: 6 x 2h (goal-setting, 
exercise (resistance), 
relaxation, problem-solving, 
communication, emotions, 
assistive devices, action plans 
and feedback) plus participant 
handbook.  No booster. 12h. 
(b) usual care 
PT (Y) CBT 3m 
21m 
ITT analysis: 
3m: SMP: pain, 
function 
21m: SMP: pain, 
function  
Buszewicz 
et al (2006) 
25
 
Patel et al 
(2006) 31 
RCT n= 812  
> 50y with hip and/or 
knee OA  
 
68y; 63% women 
Duration – not stated 
PC 
 
Drop out: 
  4m: 20% 
12m: 24% 
(a) ASMP:  6 x 2h plus 
information booklet. No 
booster. 12h. 
(b) Information booklet 
PM (Y) SCT 4 and 
12m 
ITT analysis:  
4m: ASMP: self-
efficacy, anxiety, 
depression 
12 m: ASMP: self-
efficacy, anxiety 
 
Hurley et al 
(2007a and 
b) 27,32 
Cluster RCT n=418  
>50y; chronic knee pain 
> 6m 
 
66y; 70% women 
Median Duration - 6y 
 
 
PC 
 
Drop-out: 
 
7.5m:  20%  
 
(a) Exercise and SMP 
(ESCAPE): group: 12  
sessions 2x/week for 6 
weeks (goal-setting, action 
plans, pain, pacing, 
healthy eating, relaxation, 
graded class and home 
exercise programmes). No 
booster. 12h.  
(b) ESCAPE: individual (as 
PT (not 
stated) 
SCT  7.5m ITT analysis:  
7.5m: both ESCAPE 
groups: pain, 
function, anxiety. 
Group more cost-
effective than 
individual. 
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above). 
(c)  Usual care 
Yip et al 
(2007) 29 
RCT n=182  Knee OA 
 
65y; 75% women 
Duration: 8 y 
Ortho 
 
Drop out: 
1w: 18% 
4m: 34% 
(a) Modified ASMP: 6 x 2h/wk 
plus exercise (inc. 
increased exercise: 30 mins 
Tai Chi/week, stretching, 
home walking + 
pedometer). Arthritis 
Handbook. No booster. 
12h. 
(b) usual care only 
RN (Y) SCT 1w and 
4m 
ITT analysis: 
1w: ASMP: pain, 
function,  
self-efficacy, health 
behaviors  
4m: ASMP: pain, 
function, self-efficacy, 
health behaviors 
(hot/cold packs, joint 
protection, exercise),  
Rosemann 
et al (2007) 
28
 
Cluster RCT n = 75 
practices; 1021 patients 
knee or hip OA 
 
66y; 66% women  
Duration: not stated 
 
 
 
 
PC 
 
Drop-out: 
6m 22% 
(a) GP delivered SMI: 
individual; motivating 
patients, evidence based 
self-management 
information; audio exercise 
CD; information leaflet. 
Duration not stated. 
(b)  GP-SMI plus RN monthly 
structured telephone case 
management over 6m.  
(c) Usual care 
GPs (Y); 
RN (Y) 
NS 9m ITT analysis 
9m: GP-SMI: fewer 
X-ray referrals and 
increased 
acetaminophen   
prescriptions. 
GP-SMI + case 
management: pain, 
mobility, social 
support; fewer X-ray, 
orthopedic referrals, 
increased 
acetaminophen 
prescriptions. 
 
Yip et al  
(2008) 30 
RCT n=95 Knee OA  
 
63y; 85% female 
Duration: 7y 
 
 
PC 
 
Drop Out:  
1w: 19% 
4m: 22% 
12m: 44% 
(a) Modified ASMP: 6 x 2h/wk 
plus exercise (inc. 
increased exercise: 30 mins 
Tai Chi/week, stretching, 
home walking + 
pedometer). Arthritis 
Handbook. No booster. 
12h. 
(b) Usual care only 
RN (Y) SCT 1w, 4 
and 12m  
ITT Analysis 
12m: ASMP: pain 
(overall, at night, 
when walking), global 
health, self-efficacy, 
unplanned doctor 
visits for arthritis. 
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Wetzels et 
al (2008) 26 
RCT n=104; mild hip or 
knee OA 
 
74y; 76% women 
Duration – not stated 
 
 
 
 
PC 
 
Dropout 
 
6m: 14% 
(a) Individual SMP: OA 
booklet; self-identification of 
problems; 30 min home 
visit x 1; agree to change 1 
of 4 behaviours (exercise, 
weight loss, walk aid use, 
medication); 3m telephone 
follow-up. Approx. 1h 
(b) OA booklet 
RN ( N ) NS 6m CC analysis: 
6m: no difference 
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Table 3: Studies of Self-Management in Persons with Inflammatory Arthritis only 
 
 
Author (yr) 
 
Design and Sample (n): 
Mean age (y); % women; 
arthritis duration (y) 
Recruitment 
source 
% Drop out 
 
Intervention, Duration, 
Comparison Group 
Facilitator Theory Follow-
up 
Significant Outcomes: 
Improved 
Riemsma 
et al (2003) 
33
 
RCT n= 218 RA 
 
56y; 62% women 
Duration: 12 y  
Rheum 
 
Drop-out: 
 
12m 17% 
 
(a) self-management 
programme (SMP) 5 x 2h/wk 
(pain management, relaxation, 
coping with depression, 
communication, exercise 
advice) plus 3 x 2h booster: 3, 6 
and 9 months + partner. 16h 
(b) as above without partner;  
(c ) self-help guide  only  
2x RN (Y) SCT 6 and 
12m 
ITT analysis: 
6m: Both SMP 
groups: exercise. 
12m:  SMP without 
partner: self-efficacy, 
fatigue. 
Van 
Lankveld et 
al (2004) 34 
RCT  n=59  RA 
 
50y; 65% women 
Duration: 7.2y 
 
Rheum 
 
Drop-out: 
 
6m  3% 
 
(a) Education and rational 
emotive therapy 
programme (ED-RET) 8 x 
1.5h/wk for 4 wks (ED x4: 
information; “encourage 
practice of active coping 
skills” ; 4 = RET) + partner. 
No booster. 12h. 
(b) as above without partner. 
 
No control group 
7 MDT 
members 
(not stated) 
& CP (Y) 
CBT & 
RET 
2w and 
6m 
ITT analysis: 
6m: Both ED-RET 
groups: pain, 
function, mobility, 
dexterity. 
 
Kirwan et al 
(2005) 35 
RCT (Zelen design) 
n=79 RA 
 
54y; 61% women 
Duration 15y 
Rheum 
 
Drop-out: 
 
6m   14% 
(a) education (ED) and CBT 4 
x 2.5h/week + 1 x 2.5h 
booster at 8w  (ED: joint 
protection, heat and cold; 
CBT: managing mood, 
pain, relaxation, sleep, 
communication, coping). 
12.5h. 
(b) usual care 
5 MDT 
members 
(not stated) 
+ CP & RN 
(Y) 
CBT 2 and 
6m 
ITT and CC analysis: 
CC only at 2m:  
ED-CBT: self-efficacy 
6m: no differences. 
Giraudet-le 
Quintrec et 
al (2007) 36 
RCT  n=208 RA 
 
55y; 89% women 
Rheum 
 
Drop-out: 
(a)  education and self-
management programme (ED-
SMP: ED = 3 sessions (RA, 
10 MDT 
members 
(not stated)  
SCT? 
CBT? 
6 and 
12m 
ITT analysis: 
12m: ED-SMP coping   
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Duration 13y 
 
 
 
 
12m 9% 
treatment, diet); SMP = 5 
sessions (1= pain and stress 
management; 4 = exercise, 
relaxation, joint protection, foot 
care, social advice);  8 x 6h/wk 
plus 4h booster at 6m. 52h. 
(b) information booklets 
Hammond 
et al (2008) 
37
 
RCT n=167   
(RA 50%;  EIA 35% 
PsA 15%) 
 
55y; 65% women;  
Duration 7y 
Rheum 
 
Drop-out: 
 
12m 17% 
 
 
(a) Lifestyle Management for 
Arthritis Programme (LMAP):  
2 modules: 4x 2.5h/wk; 1 x 2h 
booster (joint protection, fatigue 
management, exercise, foot 
care, managing pain and mood; 
communication, maintaining 
change); self-paced over 4-6 
months. 22h. 
(b) attention control group: 
information programme  5 x 
2h/week. 10h. 
2 OTs &  1 
PT (Y) 
 
 
 
 
 
 
 
6 MDT 
members 
(N) 
SCT 
CBT 
 
 
 
 
 
 
 
None 
6 and 
12m 
ITT analysis 
6m: LMAP: pain, 
fatigue, function, 
global health, self-
efficacy, mood, 
helplessness, 
perceived control, 
behaviours (exercise, 
joint protection), 
health care use  
12m: LMAP: pain, 
self-efficacy, 
perceived control, 
behaviours (joint 
protection, fatigue 
management) 
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Table 4: Studies of Self-Management in Persons with  Fibromyalgia only 
 
  
Author (yr) 
 
Design and Sample (n): 
Mean age (y); % women; 
arthritis duration (y) 
Recruitment 
source 
% Drop out 
 
Intervention, Duration, 
Comparison Group 
Facilitator 
Training 
(Y/N) 
Theory Follow-
up 
Significant Outcomes: 
Improved 
Soares et 
al (2002) 38 
RCT n= 53   
 
45y: 100% women 
Duration symptoms 3.6y 
PC  
 
Drop-out:  
Not stated 
 
 
Hospital-based: 
(a) Education: individual 
sessions (2x2h) + 15 x 2h 
group sessions over 10w 
(pain, sleep, stress, 
fatigue/ergonomics, 
medication, body 
awareness). No booster. 
34h. 
(b) CBT: 5 x1h individual 
sessions and 15 x 2h group 
CBT sessions over 10w 
(relaxation, biofeedback, 
pain and stress 
management, negative 
thinking, problem-solving); 
no booster. 35h. 
(c) wait list control 
 
1OT, 1PT 
(not stated) 
 
 
 
 
 
 
 
CP (Y) 
 
NS 
 
 
 
 
 
 
 
 
CBT 
2.5 and 
6m 
CC analysis: 
2.5m: CBT: pain, 
function, pain coping, 
self-efficacy,  sleep 
quality 
6m: sleep quality 
King et al 
(2002) 39 
RCT n=152 
 
46y; 100% women 
Duration 9y 
 
 
 
 
 
 
 
 
Rheum 
 
Drop-out: 
38% 
Community based: 
(a) supervised aerobic exercise  
(AE) 12 weeks (up to 40 
mins. 3 x /wk 60-75% max. 
heart-rate). 36h. 
(b) SMP: 12 x 1.5-2h/wk: pain, 
fatigue, pacing, exercise 
benefits, alternate 
therapies, barriers to 
change). 24h. 
(c) AE-SMP (combined as 
above). 50h. 
(d) Information leaflets 
 
 
 
 
 
 
MDT (not 
stated) & 
CP 
 
 
 
MDT (not 
stated) & 
CP (Y) 
 
 
 
 
 
SCT 
3 and 
6m 
ITT, CC and PP 
analyses: 
ITT and CC no 
differences 
3 and 6m: PP 
analysis only: 
AE-SMP: self-
efficacy, fitness 
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Cedraschi 
et al (2004) 
40
 
 
 
 
 
 
 
RCT n=129 
 
49y; 76% women 
Duration symptoms 9y 
Rheum 
 
Drop-out  
21% 
 
Hospital based: 
(a) SMP and exercise: 12 x 
1.5h sessions for 6 wks: land 
(x2)  and warm-water (x8) 
exercise, managing daily 
activities, relaxation, personal 
relationships. No booster. 18h.  
(b)  wait list control.  
MDT (not 
stated) & 
CP 
NS 6m CC analysis:  
6m: SMP: 
Fibromyalgia Impact 
Questionnaire (FIQ), 
pain, fatigue, 
psychological status; 
satisfaction with 
symptom control, 
stress reduction, 
memory 
Ziljstra et al 
(2005) 41 
RCT (Zelen design)  
n= 134 
 
48y; 93% women  
Duration symptoms 9y 
Rheum 
CV 
 
Drop-out: 
12m 5% 
Tunisia- hotel spa: 
(a) 2.5 weeks spa programme 
(SPA): 7 x 3hs 
thalassotherapy 7x 1h 
exercise (stretch, aerobic),  
7 x 1.5h education (role of 
emotions, pacing, stress 
handling, coping, 
medications and alternate 
therapies). No booster. 
38.5h.  
(b)  Usual care 
HP (not 
stated) 
SCT 3, 6 and 
12m 
CC analysis:  
3m: SPA: 
Fibromyalgia Impact 
Questionnaire (FIQ: 
includes pain and 
function), fatigue,  
physical health, 
tender points,  sleep 
6m: SPA: fatigue 
12m: SPA: walk time.   
Lemstra et 
al (2005) 42 
 
 
 
 
 
 
RCT n = 79 
 
 
49y; 85% women;  
Duration 10y 
PC 
 
 
Drop-out: 
3m 9% 
15m 56% 
 
 
 
 
 
Community based: 
(a) SMP and exercise (SMP-
EX). Exercise: 18 x 3 
1h/week group exercise; 
SMP (6 weeks):  FM 
information (3h), pain and 
stress management (2x3h);  
nutrition(3h); 2 x 20 mins 
individual massage. 28.7h.  
(b) Usual care 
MDT (not 
stated) & 
CP 
(cognitive 
sessions) 
NS 6w and 
15m 
(uncontr
olled) 
ITT analysis: 
6w: pain, function, 
global health, mood 
15m (uncontrolled): 
pain, function, mood  
 
Hammond 
et al (2006) 
43
 
RCT n= 183 90% 
female,  
48.5 y; 90% women 
Duration:  2.7y 
(symptoms 6.5y) 
Rheum 
 
Drop-out: 
8m 24% 
Community based: 
(a) SMP (pain, fatigue and 
stress management, pacing, 
sleep, relaxation, exercise (Tai 
Chi, home walking programme, 
postural training, strengthening)  
1OT, 1 PT 
(Y) 
SCT;   
CBT  
4 and 
8m 
ITT analysis: 
4m: SMP:  
Fibromyalgia Impact 
Questionnaire (FIQ),  
self-efficacy; 
perceived control; 
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10x 2hr/wk (over 12 weeks). No 
booster. 20h 
(b) attention control group: 
relaxation programme 10 x 1 
hr/wk for 10 weeks. 10h. 
health care use 
8 m:  exercise; self-
reported “improved” 
status 
Rooks et al 
(2007) 44 
Randomized parallel 
group study n= 207  
 
50y; 100% women;  
Duration 6y 
Rheum 
 
Drop-out: 
35% 
Community and hospital based: 
(a) aerobic exercise (AE: 
walking) 16 x 2x1h/wk + home 
programme 1x/wk; 32h. 
(b) strength and aerobic 
exercise (STAE) 16 x 2x1h/wk; 
32h. 
(c) Fibromyalgia Self-Help 
Course (FHSC) 7 x 2h/fortnight 
(pain, relaxation, exercise, 
communication, fatigue, 
depression (FM specific version 
of ASMP); no booster. 14h.  
(d) combined STAE  and 
FHSC; no booster. 46h.  
 
No control group. 
 
 
 
 
 
 
 
PM/HP? 
(Y) 
SCT 6m CC analysis: 
6m: STAE-FHSC:  
Fibromyalgia Impact 
Questionnaire (FIQ),  
pain, fatigue, 
function,  
AE: fatigue, mood; 
STAE: FIQ; pain, 
fatigue, mood 
All groups: self-
efficacy  
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Key:  
 
Diagnosis: OA = osteoarthritis; RA = rheumatoid arthritis; EIA = early inflammatory arthritis; PsA = psoriatic arthritis; FM = fibromyalgia 
 
Recruitment: CV = community volunteers; OV = online volunteers; ORTHO= Orthopedic clinic;  PC = Primary Care; Rheum = Rheumatology out-
patient departments;  CHC = Community Health Centers. 
 
Intervention: SMP = self management programme; ASMP = the Arthritis Self-Management Programme; SMART = Mail delivered Arthritis Self-
Management Programme; CDSMP: Chronic Disease Self Management Programme  
 
Programme facilitator: PM = trained peer/ lay moderator; HP = Health Professionals; RN = registered nurse; MDT: multidisciplinary team (nurse, 
physiotherapist (PT), occupational therapist (OT) (+/- rheumatologist, pharmacist); CP = clinical psychologist 
 
Training: NS = not stated.  
 
Theory: SCT = Social Cognitive Theory; CBT = cognitive-behavioural theory; NS = not stated 
 
Analysis: ITT = all cases included, imputation of missing values; CC = case completers only 
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Table 5: Outcome Measures Assessed In Clinical Trials of Self Management Interventions in Arthritis 
 
Paper Disease 
status 
Pain Fatigue Function 
/Disability 
Global 
health 
Self-
efficacy 
Mood Perceived 
control  
 
Coping Social 
support/ 
role 
Health 
behaviors 
 
Health 
care 
use/costs 
Arthritis: 
combined 
            
Lorig et al 
2004 
 *                  
Lorig et al 
2005 
 
            
  
      
Goeppinger et 
al 2007 
 
            
   
    
Laforest et al 
(2008; Nour et 
al (2006,2007) 
 
      
 
    
 
      
 
Lorig et al 
2008 
 
            
  
      
Goeppinger et 
al 2009 
 
            
   
    
 
Osteoarthritis: 
            
Victor et al 
2005 
 
  
 
    
 
      
 
  
 
Heuts et al 
2005 
 
  
 
      
      
Buszewicz et 
al 2006; Patel 
et al 2006 
 
  
 
  
 
    
    
  
Hurley et al 
2007a and b 
 
  
 
    
 
  
   
    
Rosemann et 
al (2007) 
 
  
 
  
  
  
  
  
 
  
Yip et al 2007                 
Yip et al 2008                   
Wetzels et al 
2008 
 
  
 
  
 
  
   
      
Inflammatory             
 31
Arthritis: 
Riemsma et al 
2003 
        
 
    
 
      
 
Van Lankveld 
et al 2004 
    
 
  
  
  
 
  
   
Kirwan et al 
2005 
    
 
  
 
        
   
Girardet-
leQuintrec et 
al 2007 
        
  
    
  
  
 
Hammond et 
al 2008 
EMS 
only 
              
  
    
Fibromyalgia 
only 
(Tender 
points) 
           
Soares et al 
2002 
 
            
 
    
  
King et al 
2002 
              
     
Cedraschi et 
al 2004 
 
        
 
  
  
    
 
Ziljstra et al 
2005 
          
 
  
     
Lemstra et al 
2005 
 
  
 
    
 
  
     
Hammond et 
al 2006 
 
              
  
    
Rooks et al 
2007 
 
            
  
  
  
Lorig et al 
2008 
 
        
 
  
  
      
* global severity of disease 
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TABLE 6:  Patient Perspectives on Self-Management Programs and Future Directions 
 
 
• Researchers demonstrating positive outcomes from SMIs with sufficient sample sizes, 
should undertake secondary analyses to investigate further whether any patient 
attributes are associated with better outcomes. 
•  Examine longer-term (12 months and longer) benefits of SMIs 
• Standardize implementation using protocols and participant handbooks. Ensure 
programs are SCT/CBT based, use trained peer leaders or health professionals, are of 
sufficient duration and incorporate exercise 
• Patient dairies, creative writing or interviews are recommended to explore participants’ 
overall well-being, processes of change and ascertain patient relevant outcomes  
• Researchers should include patient-relevant outcomes.  If using questionnaires, more 
frequent measures of outcomes may be useful in tracking the full impact of SMIs than 
longer intervals (baseline, 3 months and one year) 
 
 
 
 
 
 
